A two year long study of two DPP-4 inhibitors (one not available in the U.S.) found that these drugs did not, as hoped, lower the risk of heart attack in people with diabetes who took them, and they found a surprising increase in cases of heart failure among people taking Onglyza.
UPDATE 2-Doctors get good and bad safety news on diabetes drugs
http://www.reuters.com/article/2013/09/02/
.
oprah winfrey